HEADER TRANSFERASE/TRANSFERASE INHIBITOR 30-JUL-15 5CY3 TITLE SYK CATALYTIC DOMAIN COMPLEXED WITH A POTENT AND ORALLY BIOAVAILABLE TITLE 2 BENZISOTHIAZOLE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE SYK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: RESIDUES 356-635; COMPND 5 SYNONYM: SPLEEN TYROSINE KINASE,P72-SYK; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: SYK; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 7108; SOURCE 9 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PFASTBAC1 KEYWDS TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.C.LEE REVDAT 4 06-MAR-24 5CY3 1 REMARK REVDAT 3 16-DEC-15 5CY3 1 REMARK REVDAT 2 28-OCT-15 5CY3 1 JRNL REVDAT 1 23-SEP-15 5CY3 0 JRNL AUTH G.THOMA,S.VEENSTRA,R.STRANG,J.BLANZ,E.VANGREVELINGHE, JRNL AUTH 2 J.BERGHAUSEN,C.C.LEE,H.G.ZERWES JRNL TITL ORALLY BIOAVAILABLE SYK INHIBITORS WITH ACTIVITY IN A RAT JRNL TITL 2 PK/PD MODEL. JRNL REF BIOORG.MED.CHEM.LETT. V. 25 4642 2015 JRNL REFN ESSN 1464-3405 JRNL PMID 26320624 JRNL DOI 10.1016/J.BMCL.2015.08.037 REMARK 2 REMARK 2 RESOLUTION. 1.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER-TNT 2.11.5 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SMART,VONRHEIN,WOMACK, REMARK 3 : MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.91 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.3 REMARK 3 NUMBER OF REFLECTIONS : 26766 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.171 REMARK 3 R VALUE (WORKING SET) : 0.170 REMARK 3 FREE R VALUE : 0.195 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.930 REMARK 3 FREE R VALUE TEST SET COUNT : 1319 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 13 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.76 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.83 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.32 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2402 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.1954 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2296 REMARK 3 BIN R VALUE (WORKING SET) : 0.1940 REMARK 3 BIN FREE R VALUE : 0.2273 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 4.41 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 106 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2185 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 24 REMARK 3 SOLVENT ATOMS : 193 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 21.27 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 26.13 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.11760 REMARK 3 B22 (A**2) : 1.56990 REMARK 3 B33 (A**2) : -0.45230 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.67730 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.193 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.117 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.105 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.113 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.104 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.956 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.947 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2277 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3085 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 784 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 54 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 348 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2277 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 276 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : 3 ; 1.000 ; HARMONIC REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2689 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.95 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.02 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 15.49 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: { A|360 - A|637 } REMARK 3 ORIGIN FOR THE GROUP (A): 1.2456 -7.6394 -24.0533 REMARK 3 T TENSOR REMARK 3 T11: -0.0836 T22: -0.0699 REMARK 3 T33: -0.0661 T12: 0.0073 REMARK 3 T13: 0.0005 T23: 0.0131 REMARK 3 L TENSOR REMARK 3 L11: 1.3470 L22: 0.9260 REMARK 3 L33: 1.5144 L12: 0.2662 REMARK 3 L13: 0.1474 L23: 0.1102 REMARK 3 S TENSOR REMARK 3 S11: 0.0630 S12: -0.0162 S13: -0.0228 REMARK 3 S21: 0.1368 S22: -0.0493 S23: 0.0234 REMARK 3 S31: -0.0276 S32: -0.1562 S33: -0.0137 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 5CY3 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 31-JUL-15. REMARK 100 THE DEPOSITION ID IS D_1000212356. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-APR-14 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.1 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ALS REMARK 200 BEAMLINE : 5.0.3 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9765 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO, HKL-2000 REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 27534 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.750 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.04100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 12.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.79 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.50 REMARK 200 R MERGE FOR SHELL (I) : 0.41400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: REFMAC REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 43.38 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.17 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 3350 20%, AMMONIUM ACETATE 0.2M, REMARK 280 PH 7.1, VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 18.82800 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 353 REMARK 465 ALA A 354 REMARK 465 LEU A 355 REMARK 465 GLU A 356 REMARK 465 GLU A 357 REMARK 465 ILE A 358 REMARK 465 ARG A 359 REMARK 465 ALA A 408 REMARK 465 ASN A 409 REMARK 465 HIS A 638 REMARK 465 HIS A 639 REMARK 465 HIS A 640 REMARK 465 HIS A 641 REMARK 465 HIS A 642 REMARK 465 HIS A 643 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 368 CG CD CE NZ REMARK 470 LYS A 375 CD CE NZ REMARK 470 GLU A 376 CG CD OE1 OE2 REMARK 470 GLN A 391 CG CD OE1 NE2 REMARK 470 LYS A 393 CG CD CE NZ REMARK 470 LYS A 394 CG CD CE NZ REMARK 470 LYS A 397 CD CE NZ REMARK 470 GLU A 407 CG CD OE1 OE2 REMARK 470 GLU A 452 CG CD OE1 OE2 REMARK 470 LYS A 469 CD CE NZ REMARK 470 ARG A 520 NE CZ NH1 NH2 REMARK 470 LYS A 527 CE NZ REMARK 470 GLN A 529 CG CD OE1 NE2 REMARK 470 LYS A 533 CD CE NZ REMARK 470 ASP A 612 CG OD1 OD2 REMARK 470 GLU A 636 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 393 -126.49 56.02 REMARK 500 ASN A 406 74.46 55.13 REMARK 500 ALA A 441 -121.94 -135.66 REMARK 500 ASP A 494 38.50 -151.43 REMARK 500 ASP A 512 80.29 54.80 REMARK 500 TRP A 609 31.82 -89.74 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue 55Y A 701 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 5CXH RELATED DB: PDB DBREF 5CY3 A 356 635 UNP P43405 KSYK_HUMAN 356 635 SEQADV 5CY3 MET A 353 UNP P43405 INITIATING METHIONINE SEQADV 5CY3 ALA A 354 UNP P43405 EXPRESSION TAG SEQADV 5CY3 LEU A 355 UNP P43405 EXPRESSION TAG SEQADV 5CY3 THR A 467 UNP P43405 LYS 467 ENGINEERED MUTATION SEQADV 5CY3 GLU A 636 UNP P43405 EXPRESSION TAG SEQADV 5CY3 GLY A 637 UNP P43405 EXPRESSION TAG SEQADV 5CY3 HIS A 638 UNP P43405 EXPRESSION TAG SEQADV 5CY3 HIS A 639 UNP P43405 EXPRESSION TAG SEQADV 5CY3 HIS A 640 UNP P43405 EXPRESSION TAG SEQADV 5CY3 HIS A 641 UNP P43405 EXPRESSION TAG SEQADV 5CY3 HIS A 642 UNP P43405 EXPRESSION TAG SEQADV 5CY3 HIS A 643 UNP P43405 EXPRESSION TAG SEQRES 1 A 291 MET ALA LEU GLU GLU ILE ARG PRO LYS GLU VAL TYR LEU SEQRES 2 A 291 ASP ARG LYS LEU LEU THR LEU GLU ASP LYS GLU LEU GLY SEQRES 3 A 291 SER GLY ASN PHE GLY THR VAL LYS LYS GLY TYR TYR GLN SEQRES 4 A 291 MET LYS LYS VAL VAL LYS THR VAL ALA VAL LYS ILE LEU SEQRES 5 A 291 LYS ASN GLU ALA ASN ASP PRO ALA LEU LYS ASP GLU LEU SEQRES 6 A 291 LEU ALA GLU ALA ASN VAL MET GLN GLN LEU ASP ASN PRO SEQRES 7 A 291 TYR ILE VAL ARG MET ILE GLY ILE CYS GLU ALA GLU SER SEQRES 8 A 291 TRP MET LEU VAL MET GLU MET ALA GLU LEU GLY PRO LEU SEQRES 9 A 291 ASN LYS TYR LEU GLN GLN ASN ARG HIS VAL THR ASP LYS SEQRES 10 A 291 ASN ILE ILE GLU LEU VAL HIS GLN VAL SER MET GLY MET SEQRES 11 A 291 LYS TYR LEU GLU GLU SER ASN PHE VAL HIS ARG ASP LEU SEQRES 12 A 291 ALA ALA ARG ASN VAL LEU LEU VAL THR GLN HIS TYR ALA SEQRES 13 A 291 LYS ILE SER ASP PHE GLY LEU SER LYS ALA LEU ARG ALA SEQRES 14 A 291 ASP GLU ASN TYR TYR LYS ALA GLN THR HIS GLY LYS TRP SEQRES 15 A 291 PRO VAL LYS TRP TYR ALA PRO GLU CYS ILE ASN TYR TYR SEQRES 16 A 291 LYS PHE SER SER LYS SER ASP VAL TRP SER PHE GLY VAL SEQRES 17 A 291 LEU MET TRP GLU ALA PHE SER TYR GLY GLN LYS PRO TYR SEQRES 18 A 291 ARG GLY MET LYS GLY SER GLU VAL THR ALA MET LEU GLU SEQRES 19 A 291 LYS GLY GLU ARG MET GLY CYS PRO ALA GLY CYS PRO ARG SEQRES 20 A 291 GLU MET TYR ASP LEU MET ASN LEU CYS TRP THR TYR ASP SEQRES 21 A 291 VAL GLU ASN ARG PRO GLY PHE ALA ALA VAL GLU LEU ARG SEQRES 22 A 291 LEU ARG ASN TYR TYR TYR ASP VAL VAL ASN GLU GLY HIS SEQRES 23 A 291 HIS HIS HIS HIS HIS HET 55Y A 701 24 HETNAM 55Y (5R)-5-[(1R)-1-{[6-(1-METHYL-1H-PYRAZOL-4-YL)-2,1- HETNAM 2 55Y BENZOTHIAZOL-4-YL]OXY}ETHYL]-1,3-OXAZOLIDIN-2-ONE FORMUL 2 55Y C16 H16 N4 O3 S FORMUL 3 HOH *193(H2 O) HELIX 1 AA1 ASP A 366 LYS A 368 5 3 HELIX 2 AA2 PRO A 411 LEU A 427 1 17 HELIX 3 AA3 LEU A 456 ASN A 463 1 8 HELIX 4 AA4 THR A 467 SER A 488 1 22 HELIX 5 AA5 ALA A 496 ARG A 498 5 3 HELIX 6 AA6 PRO A 535 TYR A 539 5 5 HELIX 7 AA7 ALA A 540 TYR A 547 1 8 HELIX 8 AA8 SER A 550 SER A 567 1 18 HELIX 9 AA9 LYS A 577 LYS A 587 1 11 HELIX 10 AB1 PRO A 598 TRP A 609 1 12 HELIX 11 AB2 GLY A 618 GLY A 637 1 20 SHEET 1 AA1 5 LEU A 370 GLY A 380 0 SHEET 2 AA1 5 GLY A 383 MET A 392 -1 O GLY A 383 N GLY A 380 SHEET 3 AA1 5 VAL A 395 LEU A 404 -1 O ILE A 403 N THR A 384 SHEET 4 AA1 5 TRP A 444 GLU A 449 -1 O LEU A 446 N LYS A 402 SHEET 5 AA1 5 MET A 435 GLU A 440 -1 N GLY A 437 O VAL A 447 SHEET 1 AA2 3 GLY A 454 PRO A 455 0 SHEET 2 AA2 3 VAL A 500 THR A 504 -1 O LEU A 502 N GLY A 454 SHEET 3 AA2 3 TYR A 507 ILE A 510 -1 O LYS A 509 N LEU A 501 SHEET 1 AA3 2 PHE A 490 VAL A 491 0 SHEET 2 AA3 2 LYS A 517 ALA A 518 -1 O LYS A 517 N VAL A 491 SHEET 1 AA4 2 TYR A 526 LYS A 527 0 SHEET 2 AA4 2 LYS A 548 PHE A 549 -1 O PHE A 549 N TYR A 526 SITE 1 AC1 17 LEU A 377 GLY A 378 GLY A 380 VAL A 385 SITE 2 AC1 17 ALA A 400 LYS A 402 MET A 448 GLU A 449 SITE 3 AC1 17 ALA A 451 GLU A 452 GLY A 454 PRO A 455 SITE 4 AC1 17 ASN A 499 LEU A 501 SER A 511 ASP A 512 SITE 5 AC1 17 HOH A 923 CRYST1 41.504 37.656 90.888 90.00 100.14 90.00 P 1 21 1 2 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.024094 0.000000 0.004309 0.00000 SCALE2 0.000000 0.026556 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011177 0.00000